1 June 2023

CBMR publications and media appearances in June 2023

Media & Publications

Every month we release a full list of publications from the Center, as well as media appearances by the Center scientists

CBMR media and publications logo

Media Appearances

Assistant Professor Martin Grünfeld

Kunsten.nu, 21/06/2023
'Det skal være noget, der er levende og som transformerer sig over tid. Hvordan gør vi det?'



Gerhart-Hines Group

Lund J. Tracing the biological roots of obesity resistance in humans. Nat Rev Endocrinol. 2023 Jun 8. doi: 10.1038/s41574-023-00862-z. Epub ahead of print.


Grarup, Hansen Groups & Phenomics Platform

Williamson A, et al. Genome-wide association study and functional characterization identifies candidate genes for insulin-stimulated glucose uptake. Nat Genet. 2023 Jun;55(6):973-983. doi: 10.1038/s41588-023-01408-9. Epub 2023 Jun 8.


Grarup & Hansen Groups

Wibaek R, et al. Low birthweight is associated with a higher incidence of type 2 diabetes over two decades independent of adult BMI and genetic predisposition. Diabetologia. 2023 Jun 12. doi: 10.1007/s00125-023-05937-0. Epub ahead of print.


Hansen Group

Hansen AL, et al. Birthweight is associated with clinical characteristics in people with recently diagnosed type 2 diabetes. Diabetologia. 2023 Jun 12. doi: 10.1007/s00125-023-05936-1. Epub ahead of print.

Kauffmann A, et al. Maturity-onset diabetes of the young and pregnancy. Ugeskr Laeger. 2023 May 22;185(21):V02230067. Danish.

Kristensen FPB, et al. The Prevalence of Polyneuropathy in Type 2 Diabetes Subgroups Based on HOMA2 Indices of β-Cell Function and Insulin Sensitivity. Diabetes Care. 2023 Jun 19:dc230079. doi: 10.2337/dc23-0079. Epub ahead of print.

Møller M, et al. Rationale and design of a prospective, clinical study of kidney biopsies in people with type 2 diabetes and severely increased albuminuria (the PRIMETIME 2 study). BMJ Open. 2023 Jun 6;13(6):e072216. doi: 10.1136/bmjopen-2023-072216.


Juul Holst Group

Ingersen A, et al. Effects of aerobic training and semaglutide treatment on pancreatic β-cell secretory function in patients with type 2 diabetes. J Clin Endocrinol Metab. 2023 Jun 2:dgad326. doi: 10.1210/clinem/dgad326. Epub ahead of print.

Nielsen RL, et al. Appetite stimulation with cannabis-based medicine and methods for assessment of glomerular filtration in older patients with medical illness: a study protocol. Basic Clin Pharmacol Toxicol. 2023 Jun 14. doi: 10.1111/bcpt.13914. Epub ahead of print.


Loos Group

Kiryluk K, et al. Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy. Nat Genet. 2023 Jun 19. doi: 10.1038/s41588-023-01422-x. Epub ahead of print.


Pers & Schéele Groups

Palani NP, et al. Adipogenic and SWAT cells separate from a common progenitor in human brown and white adipose depots. Nat Metab. 2023 Jun 19. doi: 10.1038/s42255-023-00820-z. Epub ahead of print.


Sakamoto Group

Forteath C, et al. Amino acid homeostasis is a target of metformin therapy. Mol Metab. 2023 Jun 9:101750. doi: 10.1016/j.molmet.2023.101750. Epub ahead of print.